Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma

Cancer Immunology, Immunotherapy

Volumn 53, Issue 1, 2004, Pages 26-32

  Ito, Akira ^a   Matsuoka, Fumiko ^a   Honda, Hiroyuki ^a   Kobayashi, Takeshi ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Cancer immunotherapy; Cationic liposome; Heat shock protein; Hyperthermia; Magnetite

Indexed keywords

HEAT SHOCK PROTEIN 70; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFECT; HYPERTHERMIA; HYSTERESIS; MAGNETIC FIELD; MAGNETISM; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ELECTROMAGNETIC FIELDS; FERROSOFERRIC OXIDE; GENE THERAPY; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; IRON; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; OXIDES; RECOMBINANT PROTEINS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0742269451     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0416-5     Document Type: Article

References (39)

1. Abe M, Hiraoka M, Takahashi M, Egawa S, Matsuda C, Onoyama Y, Morita K, Kakehi M, Sugahara T (1986) Multi-institutional studies on hyperthermia using an 8-MHz radio-frequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 58:1589
2. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK (2000) HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6:435
3. Basu S, Srivastava PK (2000) Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones 5:443
4. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12:1539
5. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303
6. Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC (2000) Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 60:1035
7. Ishii T, Udono H, Yamano T, Ohta H, Uenaka A, Ono T, Hizuta A, Tanaka N, Srivastava PK, Nakayama E (1999) Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J Immunol 162:1303
8. Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T (2001) Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 50:515
9. Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, Yoshida J, Kobayashi T (2003) Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother 52:80
10. Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, Saida T, Kobayashi T (2003) Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 94:308
11. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R (1993) Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia 9:51
12. Kubista B, Trieb K, Blahovec H, Kotz R, Micksche M (2002) Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis. Anticancer Res 22:789
13. Li Z, Menoret A, Srivastava P (2002) Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr Opin Immunol 14:45
14. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG (1998) Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 4:581
15. Ménoret A, Chandawarkar R (1998) Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. Sem Immunol 25:654
16. Ménoret A, Patry Y, Burg C, Le Pendu J (1995) Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas. J Immunol 155:740
17. Ménoret A, Chaillot D, Callahan M, Jacquin C (2002) Hsp70, an immunological actor playing with the intracellular self under oxidative stress. Int J Hyperthermia 18:490
18. Minamimura T, Sato H, Kasaoka S, Saito T, Ishizawa S, Takemori S, Tazawa K, Tsukada K (2000) Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol 16:1153
19. Mise K, Kan N, Okino T, Nakanishi M, Satoh K, Teramura Y, Yamasaki S, Ohgaki K, Tobe T (1990) Effect of heat treatment on tumor cells and antitumor effector cells. Cancer Res 50:6199
20. Mondovi B, Santoro AS, Strom R, Faiola R, Fanelli AR (1972) Increased immunogenicity of Ehrlich ascites cells after heat treatment. Cancer 30:885
21. Moroz P, Jones SK, Gray BN (2002) Magnetically mediated hyperthermia: current status and future directions. Int J Hyperthermia 18:267
22. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, Massie B (2000) The chaperon function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 20:7146
23. + TH1 clones on heat-shocked tumor targets, I: implications for internal disintegration model for target death and hyperthermia treatment of cancers. J Immunol 147:4027
24. Parmiani G, Castelli C, Dalerba P, Mortarini R, Rivoltini L, Marincola FM, Anichini A (2002) Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? J Natl Cancer Inst 94:805
25. Schlesinger MJ (1990) Heat shock proteins. J Biol Chem 265:12111
26. Shinkai M, Matsui M, Kobayashi T (1994) Heat properties of magnetoliposomes for local hyperthermia. Jpn J Hyperthermic Oncol 10:168
27. Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T (1996) Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn J Cancer Res 87:1179
28. Srivastava PK, Menoret A, Basu S, Binder RJ, McQuade KL (1998) Heat shock proteins come of age: primitive functions acquired new roles in an adaptive world. Immunity 8:657
29. Suzuki M, Shinkai M, Honda H, Kobayashi T (2003) Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 13:129
30. Tamura Y, Peng P, Liu K, Daou M, Srivastava PK (1997) Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278:117
31. Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A, Vile RG (1999) Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol 163:1398
32. Udono H, Srivastava PK (1993) Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178:1391
33. Udono H, Srivastava PK (1994) Comparison of tumor-specific immunogenicities of stress-induced protein gp96, hsp90, and hsp70. J Immunol 152:5398
34. Van der Zee J (2002) Heating the patient: a promising approach? Annu Oncol 13:1173
35. Wallen ES, Buettner GR, Moseley PL (1997) Oxidants differentially regulate the heat shock response. Int J Hyperthermia 13:517
36. Wells AD, Rai SK, Salvato MS, Band H, Malkovsky M (1998) Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int Immunol 10:609
37. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T (1997) Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res 88:630
38. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T (1998) Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn J Cancer Res 89:463
39. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T (1998) Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res 89:775